Publications

Back to Publications

Stay up to date with our literature reviews which are curated by experts to feature the most important publications released each month. Explore our publications for access to concise summary slides for your own use.

Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

Circulation 2022;145:575–85 doi: 10.1161/CIRCULATIONAHA.121.055459

The effects of once-weekly semaglutide and once-daily liraglutide were assessed. Pooled and by-trial data from SUSTAIN 6 and LEADER were assessed for albuminuria change, eGFR change, and time to persistent eGFR reduction from baseline.


LinkedIn